Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Sep;102(9):2912-23.
doi: 10.1002/jps.23570. Epub 2013 May 24.

The utility of modeling and simulation in drug development and regulatory review

Shiew-Mei Huang  1 , Darrell R Abernethy, Yaning Wang, Ping Zhao, Issam Zineh
Affiliations
Review

The utility of modeling and simulation in drug development and regulatory review

Shiew-Mei Huang et al. J Pharm Sci. 2013 Sep.

Abstract

US Food and Drug Administration (FDA) has identified innovation in clinical evaluations as a major scientific priority area. This paper provides case studies and updates to describe the efforts by the FDA's Office of Clinical Pharmacology in its development and application of regulatory science, focusing on modeling and simulation. Key issues and challenges are identified that need to be addressed to promote the uptake of modeling and simulation approaches in drug regulation. Published 2013. This article is a U.S. Government work and is in the public domain in the USA. 102:2912-2923, 2013.

Keywords: Modeling and simulation; PBPK; dose-response; drug interactions; pharamcokinetics; pharmacodynamics; regulatory science; systems pharmacology.

PubMed Disclaimer